Contact: Julia Chapman, 914-740-2100, firstname.lastname@example.org
Groundbreaking Journal on Caffeine Research To Launch in Spring 2011 from Mary Ann Liebert, Inc., publishers
New Rochelle, NY, October 21, 2010—Caffeine is consumed in the daily diet of most people around the globe—in coffee, tea, cola, energy drinks, chocolate, and over-the-counter and prescription medications. Until now, there has been no central forum for the publication of scientific studies on the wide range of potential health effects of caffeine. Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a new quarterly peer-reviewed journal from Mary Ann Liebert, Inc., will provide a much-needed authoritative source to advance knowledge of caffeine science and caffeine’s effects on human health. A full description of the Journal is available online.
Caffeine’s popularity far exceeds that of any other psychoactive substance, including nicotine, alcohol, and all illicit drugs. Journal of Caffeine Research will publish original research, discussion, and debate about the possible effects of caffeine on a wide range of diseases and conditions, including mood disorders, neurological disorders, cognitive performance, cardiovascular disease, and sports performance. The Journal will explore all aspects of caffeine science including the biochemistry of caffeine; its actions on the human body; benefits, dangers, and contraindications; and caffeine addiction and withdrawal, across all stages of the human life span from prenatal exposure to end-of-life. The Journal will be inclusive with respect to the diversity of research methodologies used to investigate caffeine, and the diversity of views and opinions regarding its mechanisms and effects, and will combine the scientific research and clinical studies on caffeine, with an impact across many fields.
Journal of Caffeine Research is under the editorial leadership of Editor-in-Chief Jack E. James, PhD, School of Psychology, National University of Ireland, Galway, Ireland and a distinguished multidisciplinary editorial board that includes Roland Griffiths, PhD, Johns Hopkins School of Medicine; James Lane, PhD, Duke University Medical School; Sergi Ferre, MD, PhD, National Institute on Drug Abuse; and Mary Claire O’Brien, MD, Wake Forest University School of Medicine, and other leading investigators. Please visit our website to view the entire editorial board.
"There is a strong imperative for a dedicated multidisciplinary forum to ensure that research advances are well disseminated, and the effects of caffeine, both positive and negative, are well understood,” says Mary Ann Liebert, president of Mary Ann Liebert, Inc.